Executive Functions Computerized Rehabilitation Using Virtual Reality to Improve Activities of Daily Living Post-stroke
NCT ID: NCT04855903
Last Updated: 2023-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
27 participants
INTERVENTIONAL
2021-09-21
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telerehabilitation Through Serious Games in Virtual Reality in a Stroke Population (AutoRReVi)
NCT04694833
Multi-domain Improvements in High-TEchnology Rehabilitation Programs for Post-stroke Patients
NCT06489145
Virtual Action Planning in Stroke: a Control Rehabilitation Study
NCT01365858
Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
NCT06053619
Effect of Upper Extremity Rehabilitation Using Immersive Virtual Reality in Chronic Stroke Patients.
NCT05148052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pretreatment includes a routine sensitivomotor neurological rehabilitation program that doesn't specifically target executive functions in daily living activities (3 to 5 weeks depending on randomization). Treatment consists in a 4 weeks virtual reality cognitive training program, including four 45-minute sessions per week with an occupational therapist for cognitive rehabilitation in a virtual environment with the COVIRTUA Cognition software. The follow-up phase (5 to 3 weeks depending on randomization) includes no support for executive functions, either in a rehabilitation centre or in a liberal office.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1 (early phase B)
2 phases of cognitive training: Phase A : rehabilitation program in standard ergotherapy during 3 weeks Phase B : cognitive training using Covirtua Cognition software during 4 weeks
These 2 phases will be followed by a follow-up phase during 5 weeks
Covirtua Cognition software
Cognitive training with Covirtua Cognition software
Arm 2 (mid phase B)
2 phases of cognitive training: Phase A : rehabilitation program in standard ergotherapy during 4 weeks Phase B : cognitive training using Covirtua Cognition software during 4 weeks
These 2 phases will be followed by a follow-up phase during 4 weeks
Covirtua Cognition software
Cognitive training with Covirtua Cognition software
Arm 3 (late phase B)
2 phases of cognitive training: Phase A : rehabilitation program in standard ergotherapy during 5 weeks Phase B : cognitive training using Covirtua Cognition software during 4 weeks
These 2 phases will be followed by a follow-up phase during 3 weeks
Covirtua Cognition software
Cognitive training with Covirtua Cognition software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Covirtua Cognition software
Cognitive training with Covirtua Cognition software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women over the age of 18
* Presence of a caregiver
* Social Security affiliation
* Signing free and informed consent following clear and detailed information
* Sufficient understanding of the French language to participate in the study
Exclusion Criteria
* Alcohol and/or narcotics addiction
* Major hearing deficit
* Major visual deficit
* Neurological pathology other than stroke or psychiatric disorder
* Unstable epilepsy
* Patient undergoing rehabilitation at a liberal therapist targeting executive functions during study time
* Patient under safeguard of justice.
* Patient simultaneously participating in another research study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emilie CATELLA
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de la Tour de Gassies
Bruges, , France
Hôpital Swynghedauw
Lille, , France
University hospital of Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Amandine CONSTANT-COOK
Role: primary
Etienne ALLART
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/19/0552
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.